These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 788758)

  • 1. The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased.
    Wilson M; Morgan G; Morgan T
    Br J Clin Pharmacol; 1976 Oct; 3(5):857-61. PubMed ID: 788758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
    Morgan TO; Roberts R; Carney SL; Louis WJ; Doyle AE
    Br J Clin Pharmacol; 1975 Apr; 2(2):159-64. PubMed ID: 791319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect on blood pressure of beta-adrenoreceptor-blocking drugs given once daily.
    Wilson M; Morgan G; Morgan T
    Clin Sci Mol Med Suppl; 1976 Dec; 3():527s-528s. PubMed ID: 1071674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol.
    England JD
    Aust N Z J Med; 1981 Feb; 11(1):35-40. PubMed ID: 7018482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
    Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in plasma renin activity and blood pressure after acute and chronic administration of beta-adrenergic receptor-blocking drugs.
    Morgan T; Carney S; Roberts R
    Clin Sci Mol Med Suppl; 1975 Jun; 2():81s-83s. PubMed ID: 802647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study.
    van den Meiracker AH; Man in't Veld AJ; Schalekamp MA
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):39S-44S. PubMed ID: 3326634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-a-day pindolol in hypertension.
    Traub YM; Rosenfeld JB
    Clin Pharmacol Ther; 1977 May; 21(5):588-92. PubMed ID: 322923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
    Kralberg BE; Tolagen K
    Am J Med; 1976 May; 60(6):891-6. PubMed ID: 14504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of antihypertensive effect of beta-adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis.
    Durão V; Prata MM; Gonçalves LM
    Lancet; 1977 Nov; 2(8046):1005-7. PubMed ID: 72901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
    Potempa KM; Fogg LF; Fish AF; Kravitz HM
    Heart Lung; 1993; 22(5):383-91. PubMed ID: 8226001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pindolol: effects on blood pressure and plasma renin activity.
    Glassock RJ; Weitzman RE; Bennett CM; Maxwell M; Hamilton B; Winer N; Kirkendall W; Gonasun L
    Am Heart J; 1982 Aug; 104(2 Pt 2):421-5. PubMed ID: 7048878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol in the control of blood pressure: a dose-response study.
    Serlin MJ; Orme ML; Baber NS; Sibeon RG; Laws E; Breckenridge A
    Clin Pharmacol Ther; 1980 May; 27(5):586-92. PubMed ID: 6102895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers and plasma renin activity in hypertension.
    Stokes GS; Weber MA; Thornell IR
    Br Med J; 1974 Jan; 1(5897):60-2. PubMed ID: 4149613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of pindolol and hydrochlorothiazide on blood pressure, and plasma renin and plasma lipid levels.
    Johnson BF; Weiner B; Marwaha R; Johnson J
    J Clin Pharmacol; 1986 Apr; 26(4):258-63. PubMed ID: 3517076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative beta-adrenoreceptor-blocking effects and pharmacokinetics or propranolol and pindolol in hypertensive Africans.
    Salako LA; Falase AO; Aderounmu AF
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():393s-396s. PubMed ID: 232026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
    Velasco M; Morillo J; Ramirez A; Hernández E; Vizcarrondo H; Urbin-Aquintana A; López JM; Medrano G; Hernández-Pieretti O
    Int J Clin Pharmacol Res; 1983; 3(2):95-100. PubMed ID: 6384072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure.
    Stumpe KO; Kolloch R; Vetter H; Gramann W; Krück F; Ressel C; Higuchi M
    Am J Med; 1976 May; 60(6):853-65. PubMed ID: 14499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term blood pressure control with pindolol given once daily.
    Frithz G; Danielson M; Henningsen N; Malmborg RO; Nordström-Ohrberg G; Schröder G
    Eur J Cardiol; 1978; 7(2-3):131-6. PubMed ID: 27369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.